TRCT
LBMH

Tower Research Capital (TRC)’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Tower Research Capital (TRC)’s Portfolio LBMH Stock Details LBMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-18
Closed – – 5612
2015
Q3 		$0 Sell
18
-1,927
-99% -$4.63K ﹤0.01% 5449
2015
Q2 		$4K Buy
1,945
+1,827
+1,548% +$5.29K ﹤0.01% 3481
2015
Q1 		$0 Sell
118
-286
-71% -$976 ﹤0.01% 5396
2014
Q4 		$1K Sell
404
-19,364
-98% -$54.6K ﹤0.01% 3870
2014
Q3 		$62K Buy
19,768
+19,234
+3,602% +$60.8K 0.01% 1359
2014
Q2 		$2K Buy
534
+49
+10% +$190 ﹤0.01% 3554
2014
Q1 		$2K Buy
485
+425
+708% +$1.86K ﹤0.01% 4004
2013
Q4 		$0 Buy
+60
New +$222 ﹤0.01% 5273

Other funds holding LBMH

GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Tower Research Capital (TRC)'s LBMH Position: Q4 2015 in Review

Tower Research Capital (TRC) sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q4 2015, closing a stake of 18 shares.

Tower Research Capital (TRC) first reported a position in LBMH in Q4 2013 and held it in 8 quarters. The position peaked at $62K in Q3 2014. 54 funds tracked by Wall St. Rank hold LBMH as of Q4 2015.

  • Tower Research Capital (TRC) reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q4 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 18 LIBERATOR MED HLDGS INC (NY) shares in Q4 2015.
  • Tower Research Capital (TRC) first reported a position in LIBERATOR MED HLDGS INC (NY) in Q4 2013 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s LIBERATOR MED HLDGS INC (NY) position peaked at $62K in Q3 2014.
  • 54 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q4 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.